These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 27845500)

  • 21. Different vascular smooth muscle cell apoptosis in the human internal mammary artery and the saphenous vein. Implications for bypass graft disease.
    Frischknecht K; Greutert H; Weisshaupt C; Kaspar M; Yang Z; Luscher TF; Carrel TP; Tanner FC
    J Vasc Res; 2006; 43(4):338-46. PubMed ID: 16733369
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distribution of endothelin-1 (ET) receptors (ET(A) and ET(B)) and immunoreactive ET-1 in porcine saphenous vein-carotid artery interposition grafts.
    Dashwood MR; Mehta D; Izzat MB; Timm M; Bryan AJ; Angelini GD; Jeremy JY
    Atherosclerosis; 1998 Apr; 137(2):233-42. PubMed ID: 9622266
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Temporal PTEN inactivation causes proliferation of saphenous vein smooth muscle cells of human CABG conduits.
    Mitra AK; Jia G; Gangahar DM; Agrawal DK
    J Cell Mol Med; 2009 Jan; 13(1):177-87. PubMed ID: 18363844
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bypass graft disease: analysis of proliferative activity in human aorto-coronary bypass grafts.
    Hilker M; Buerke M; Lehr HA; Oelert H; Hake U
    Heart Surg Forum; 2002; 5 Suppl 4():S331-41. PubMed ID: 12759206
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selective gene silencing of either MMP-2 or MMP-9 inhibits invasion of human saphenous vein smooth muscle cells.
    Turner NA; Hall KT; Ball SG; Porter KE
    Atherosclerosis; 2007 Jul; 193(1):36-43. PubMed ID: 16979647
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gene delivery to aortocoronary saphenous vein grafts in a large animal model of intimal hyperplasia.
    Petrofski JA; Hata JA; Gehrig TR; Hanish SI; Williams ML; Thompson RB; Parsa CJ; Koch WJ; Milano CA
    J Thorac Cardiovasc Surg; 2004 Jan; 127(1):27-33. PubMed ID: 14752409
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of hemodynamic forces in the ex vivo arterialization of human saphenous veins.
    Berard X; Déglise S; Alonso F; Saucy F; Meda P; Bordenave L; Corpataux JM; Haefliger JA
    J Vasc Surg; 2013 May; 57(5):1371-82. PubMed ID: 23351647
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Simvastatin inhibits human saphenous vein neointima formation via inhibition of smooth muscle cell proliferation and migration.
    Porter KE; Naik J; Turner NA; Dickinson T; Thompson MM; London NJ
    J Vasc Surg; 2002 Jul; 36(1):150-7. PubMed ID: 12096273
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of osteopontin in the development of neointimal hyperplasia in vein grafts.
    Kang N; Ng CS; Hu J; Qiu ZB; Underwood MJ; Jeremy JY; Wan S
    Eur J Cardiothorac Surg; 2012 Jun; 41(6):1384-9. PubMed ID: 22219474
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Type 2 diabetes impairs venous, but not arterial smooth muscle cell function: possible role of differential RhoA activity.
    Riches K; Warburton P; O'Regan DJ; Turner NA; Porter KE
    Cardiovasc Revasc Med; 2014 Apr; 15(3):141-8. PubMed ID: 24642103
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunohistochemical and ultrastructural examination of smooth muscle cells in aortocoronary saphenous vein grafts.
    Yamada T; Shiraishi R; Taki K; Nakano S; Tokunaga O; Itoh T
    Angiology; 1997 May; 48(5):381-90. PubMed ID: 9158382
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Wound healing around and within saphenous vein bypass grafts.
    O'Brien JE; Shi Y; Fard A; Bauer T; Zalewski A; Mannion JD
    J Thorac Cardiovasc Surg; 1997 Jul; 114(1):38-45. PubMed ID: 9240292
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gene transfer of the urokinase-type plasminogen activator receptor-targeted matrix metalloproteinase inhibitor TIMP-1.ATF suppresses neointima formation more efficiently than tissue inhibitor of metalloproteinase-1.
    Lamfers ML; Grimbergen JM; Aalders MC; Havenga MJ; de Vries MR; Huisman LG; van Hinsbergh VW; Quax PH
    Circ Res; 2002 Nov; 91(10):945-52. PubMed ID: 12433840
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The Association Between Bone Morphogenic Protein-4 and
    Zhang HW; Gu J; Zhang EY; Guo YQ; Wu Z; Gan CP; Fan KJ; Xiao ZH; Hu J
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2016 Sep; 47(5):738-742. PubMed ID: 28598090
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Remodeling of autologous saphenous vein grafts. The role of perivascular myofibroblasts.
    Shi Y; O'Brien JE; Mannion JD; Morrison RC; Chung W; Fard A; Zalewski A
    Circulation; 1997 Jun; 95(12):2684-93. PubMed ID: 9193438
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential expression and activity of matrix metalloproteinases during flow-modulated vein graft remodeling.
    Berceli SA; Jiang Z; Klingman NV; Pfahnl CL; Abouhamze ZS; Frase CD; Schultz GS; Ozaki CK
    J Vasc Surg; 2004 May; 39(5):1084-90. PubMed ID: 15111865
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Involvement of dendritic cells in long-term aortocoronary saphenous vein bypass graft failure.
    Cherian SM; Bobryshev YV; Inder SJ; Lord RS; Reddi KH; Farnsworth AE; Tran D; Munro VF; Ashwell KW
    Cardiovasc Surg; 1999 Aug; 7(5):508-18. PubMed ID: 10499893
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Injury induces dedifferentiation of smooth muscle cells and increased matrix-degrading metalloproteinase activity in human saphenous vein.
    Johnson JL; van Eys GJ; Angelini GD; George SJ
    Arterioscler Thromb Vasc Biol; 2001 Jul; 21(7):1146-51. PubMed ID: 11451743
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Short-term exposure to thapsigargin inhibits neointima formation in human saphenous vein.
    George SJ; Johnson JL; Angelini GD; Jeremy JY
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2500-6. PubMed ID: 9409220
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vascular reactivity and flow characteristics of radial artery and long saphenous vein coronary bypass grafts: a 5-year follow-up.
    Webb CM; Moat NE; Chong CF; Collins P
    Circulation; 2010 Aug; 122(9):861-7. PubMed ID: 20713903
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.